A Phase I Single Center Study to Evalute the Safety, Tolerability and Pharmacokinetics of Intravenous IdeS After Administration of Single Ascending Doses in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2017
At a glance
- Drugs Imlifidase (Primary)
- Indications Transplant rejection
- Focus Adverse reactions; First in man; Proof of concept
- Sponsors Hansa Medical AB
- 16 Jul 2015 According to Hansa Medical AB media release, results have been published in PLOS ONE.
- 16 Jul 2015 Results published in Hansa Medical AB media release.
- 18 Feb 2015 Results published in Hansa Medical AB media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History